Fibrous structures comprising volatile agave compounds

Abstract

The disclosure provides fibrous structures and tissue products comprising a volatile agave compound selected from the group consisting of limonene, hexanaldehyde and 6-Methyl-5-hepten-2-one. The volatile agave compounds may be provided by forming the structures at least in-part from agave fiber, such as Agave tequilana fiber. In other embodiments the volatile agave compounds may be incorporated in the fibrous structures by adding the compounds during formation of the fibrous structure, such as by adding the compounds to the furnish, or by topically applying the compounds to the fibrous structure after formation, in order to provide a lemon-like scent to the fibrous structure.

What is claimed is: 
     
         1 . A fibrous structure comprising at least about 0.5 percent, by weight of the fibrous structure, agave fiber and a volatile agave compound selected from the group consisting of limonene, hexanaldehyde and 6-Methyl-5-hepten-2-one and combinations thereof. 
     
     
         2 . The fibrous structure of  claim 1  wherein the fibrous structure comprises at least about 10 ppb limonene. 
     
     
         3 . The fibrous structure of  claim 1  wherein the fibrous structure comprises from about 10 to about 200 ppb limonene and from about 50 to about 500 ppb 6-Methyl-5-hepten-2-one. 
     
     
         4 . The fibrous structure of  claim 1  wherein the fibrous structure comprises from about 1.0 to about 40 percent, by weight of the fibrous structure, agave fiber and from 60 to about 99 percent, by weight of the fibrous structure, wood pulp fibers. 
     
     
         5 . The fibrous structure of  claim 4  wherein the agave fibers are high yield agave pulp fibers. 
     
     
         6 . The fibrous structure of  claim 1  wherein the fibrous structure comprises a throughdried fibrous structure. 
     
     
         7 . The fibrous structure of  claim 1  wherein the fibrous structure comprises an uncreped through-air dried fibrous structure. 
     
     
         8 . The fibrous structure of  claim 1  having a first and a second side and a formulation comprising a volatile agave compound selected from the group consisting of limonene, hexanaldehyde and 6-Methyl-5-hepten-2-one and combinations thereof and a carrier disposed on the first or second side. 
     
     
         9 . A tissue product comprising at least one tissue web, the tissue web comprising at least about 0.5 percent, by weight of the fibrous structure, agave fiber and a volatile agave compound selected from the group consisting of limonene, hexanaldehyde and 6-Methyl-5-hepten-2-one and combinations thereof, the product having a basis weight from about 10 to about 60 gsm, a geometric mean tensile (GMT) greater than about 400 g/3″ and a sheet bulk greater than about 5.0 cc/g. 
     
     
         10 . The tissue product of  claim 9  wherein the fibrous structure comprises at least about 10 ppb limonene. 
     
     
         11 . The tissue product of  claim 9  wherein the fibrous structure comprises from about 10 to about 200 ppb limonene and from about 50 to about 500 ppb 6-Methyl-5-hepten-2-one. 
     
     
         12 . The tissue product of  claim 9  wherein the fibrous structure comprises from about 1.0 to about 40 percent, by weight of the fibrous structure, agave fiber and from 60 to about 99 percent, by weight of the fibrous structure, wood pulp fibers. 
     
     
         13 . The tissue product of  claim 9  wherein the tissue web is a creped tissue web. 
     
     
         14 . A method of manufacturing a tissue web having a lemon-like odor comprising the steps of:
 a. Forming a fiber slurry comprising agave fiber and wood pulp fiber;   b. Forming a tissue web from the fiber slurry, the web having a first and a second side; and   c. Depositing on at least a first side of the web a formulation comprising a volatile agave compound selected from the group consisting of limonene, hexanaldehyde and 6-Methyl-5-hepten-2-one and combinations thereof and a carrier.   
     
     
         15 . The method of  claim 14  wherein the tissue web comprises at least about 10 ppb limonene. 
     
     
         16 . The method of  claim 14  wherein the tissue web comprises from about 10 to about 200 ppb limonene and from about 50 to about 500 ppb 6-Methyl-5-hepten-2-one. 
     
     
         17 . The method of  claim 14  wherein the volatile agave compounds comprise from about 0.0001 to 0.5 percent, by weight of the formulation. 
     
     
         18 . The method of  claim 14  wherein the carrier is selected from group consisting of water, emollients, fatty acids, fatty alcohols, humectants, thickeners and combinations thereof. 
     
     
         19 . The method of  claim 14  wherein the carrier is a water and oil emulsion and comprises from about 35 to about 60 percent, by weight of the formulation. 
     
     
         20 . The method of  claim 14  wherein the tissue web comprises from about 1.0 to about 30 percent, by weight of the tissue web, agave fiber.